Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Local Reg Anesth ; 9: 65-81, 2016.
Article in English | MEDLINE | ID: mdl-27785097

ABSTRACT

A systematic review of the literature on the use of regional anesthesia (RA) and patient-controlled analgesia (PCA) was conducted in patients who require orthopedic extremity procedures to determine whether either analgesic technique contributes to a delayed diagnosis of compartment syndrome (CS). A total of 34 relevant articles (28 case reports and six research articles) were identified. Of all case report articles published after 2009, the majority (75%) concluded that RA does not put the patient at an increased risk of a delayed diagnosis of CS. Of these, only two relevant prospective research studies focusing on RA or PCA and their relationship to CS were identified. Neither study resulted in any cases of CS. However, both had relatively small sample sizes. Given the lack of evidence identified in this systematic review, prospective studies or large-scale retrospective data reviews are needed to more strongly advocate the use of one modality of analgesia over the other in this patient population.

2.
Am J Physiol Cell Physiol ; 303(1): C4-C13, 2012 Jul 01.
Article in English | MEDLINE | ID: mdl-22378745

ABSTRACT

AMP-activated protein kinase (AMPK) and the NAD(+)-dependent histone/protein deacetylase sirtuin 1 (SIRT1) are metabolic sensors that can increase each other's activity. They are also both activated by the antidiabetic drug metformin and downregulated in the liver under conditions of nutrient excess (e.g., hyperglycemia, high-fat diet, obesity). In these situations, the abundance of the tumor suppressor p53 is increased; however, the relevance of this to the changes in AMPK and SIRT1 is not known. In the present study we investigated this question in HepG2 cells under high glucose conditions. Metformin induced activation of AMPK and SIRT1 and decreased p53 protein abundance. It also decreased triglyceride accumulation and cytosolic oxidative stress (a trigger for p53 accumulation) and increased the deacetylation of p53 at a SIRT1-targeted site. The decrease in p53 abundance caused by metformin was abolished by inhibition of murine double minute 2 (MDM2), a ubiquitin ligase that mediates p53 degradation, as well as by overexpression of a dominant-negative AMPK or a shRNA-mediated knockdown of SIRT1. In addition, overexpression of p53 decreased SIRT1 gene expression and protein abundance, as well as AMPK activity in metformin-treated cells. It also diminished the triglyceride-lowering action of metformin, an effect that was rescued by incubation with the SIRT1 activator SRT2183. Collectively, these findings suggest the existence of a novel reciprocal interaction between AMPK/SIRT1 and p53 that may have implications for the pathogenesis and treatment of metabolic diseases.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Glucose/pharmacology , Metformin/pharmacology , Sirtuin 1/metabolism , Tumor Suppressor Protein p53/metabolism , Glucose/metabolism , Hep G2 Cells , Heterocyclic Compounds, 4 or More Rings/pharmacology , Humans , Oxidative Stress/drug effects , Proto-Oncogene Proteins c-mdm2/antagonists & inhibitors , RNA Interference , RNA, Small Interfering , Sirtuin 1/genetics , Triglycerides/biosynthesis
3.
Biochem Biophys Res Commun ; 378(4): 836-41, 2009 Jan 23.
Article in English | MEDLINE | ID: mdl-19071085

ABSTRACT

We examined in HepG2 cells whether glucose-induced changes in AMP-activated protein kinase (AMPK) activity could be mediated by SIRT1, an NAD(+)-dependent histone/protein deacetylase that has been linked to the increase in longevity caused by caloric restriction. Incubation with 25 vs. 5mM glucose for 6h concurrently diminished the phosphorylation of AMPK (Thr 172) and ACC (Ser 79), increased lactate release, and decreased the abundance and activity of SIRT1. In contrast, incubation with pyruvate (0.1 and 1mM) for 2h increased AMPK phosphorylation and SIRT1 abundance and activity. The putative SIRT1 activators resveratrol and quercetin also increased AMPK phosphorylation. None of the tested compounds (low or high glucose, pyruvate, and resveratrol) significantly altered the AMP/ATP ratio. Collectively, these findings raise the possibility that glucose-induced changes in AMPK are linked to alterations in SIRT1 abundance and activity and possibly cellular redox state.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Glucose/metabolism , Sirtuins/metabolism , Adenosine Monophosphate/metabolism , Adenosine Triphosphate/metabolism , Animals , Cell Line , Glucose/pharmacology , Humans , Muscles/drug effects , Muscles/metabolism , Niacinamide/pharmacology , Oxidation-Reduction , Phosphorylation/drug effects , Pyruvic Acid/pharmacology , Quercetin/pharmacology , Rats , Resveratrol , Serine/metabolism , Sirtuin 1 , Sirtuins/antagonists & inhibitors , Stilbenes/pharmacology , Threonine/metabolism
4.
Mol Biol Cell ; 16(2): 676-88, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15563608

ABSTRACT

Activation of G-protein-coupled chemoattractant receptors triggers dissociation of Galpha and Gbetagamma subunits. These subunits induce intracellular responses that can be highly polarized when a cell experiences a gradient of chemoattractant. Exactly how a cell achieves this amplified signal polarization is still not well understood. Here, we quantitatively measure temporal and spatial changes of receptor occupancy, G-protein activation by FRET imaging, and PIP3 levels by monitoring the dynamics of PH(Crac)-GFP translocation in single living cells in response to different chemoattractant fields. Our results provided the first direct evidence that G-proteins are activated to different extents on the cell surface in response to asymmetrical stimulations. A stronger, uniformly applied stimulation triggers not only a stronger G-protein activation but also a faster adaptation of downstream responses. When naive cells (which have not experienced chemoattractant) were abruptly exposed to stable cAMP gradients, G-proteins were persistently activated throughout the entire cell surface, whereas the response of PH(Crac)-GFP translocation surprisingly consisted of two phases, an initial transient and asymmetrical translocation around the cell membrane, followed by a second phase producing a highly polarized distribution of PH(Crac)-GFP. We propose a revised model of gradient sensing, suggesting an important role for locally controlled components that inhibit PI3Kinase activity.


Subject(s)
Chemotactic Factors/metabolism , Dictyostelium/cytology , Dictyostelium/metabolism , GTP-Binding Proteins/drug effects , Signal Transduction , Animals , Cell Membrane/metabolism , Cell Polarity , Chemotactic Factors/pharmacology , Cyclic AMP/pharmacology , Cytosol/metabolism , Dictyostelium/drug effects , Dose-Response Relationship, Drug , Enzyme Activation , Fluorescence Resonance Energy Transfer , Fluorescent Dyes , GTP-Binding Proteins/metabolism , Green Fluorescent Proteins/metabolism , Image Processing, Computer-Assisted , Kinetics , Microscopy, Confocal , Organic Chemicals , Phosphatidylinositol 3-Kinases/analysis , Phosphatidylinositol 3-Kinases/drug effects , Phosphoinositide-3 Kinase Inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...